Business

Announcement on Obtaining FDA Approval by Subsidiary for Propofol Injectable Emulsion

Announcement on Obtaining FDA Approval by Subsidiary for Propofol Injectable Emulsion

articleNanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class ADecember 3, 20254/news/announcement-on-obtaining-fda-approval-by-subsidiary-for-propofol-injectable-emulsion
Announcement on Obtaining FDA Approval by Subsidiary for Propofol Injectable Emulsion

About this update from Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A

Announcement on Obtaining FDA Approval by Subsidiary for Propofol Injectable Emulsion The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A